Patient no. | Age (y) | Sex | PET/CT indication | SUV range of lesions | 3D PET/CT helpful for radiologic interpretation? | Type of procedure performed after 3D PET/CT (if any) | 3D PET/CT helpful for preprocedural planning? |
---|---|---|---|---|---|---|---|
1 | 86 | M | Head/neck staging | 4.3 | No | Bronchoscopy | Yes |
2 | 89 | F | Esophageal staging | 7.2−17.5 | No | Mediastinoscopy | Yes |
3 | 81 | M | Lung restaging | 5.3−8.4 | No | ||
4 | 87 | M | Lung staging | 2.7−6.1 | No | Mediastinoscopy | Yes |
5 | 56 | F | Lung staging | 7.0−18.8 | No | ||
6 | 72 | F | Esophageal staging | 3.8 | Yes | Endoscopy | Yes |
7 | 60 | M | Esophageal staging | 2.9−3.8 | No | Mediastinoscopy | Yes |
8 | 31 | F | Breast staging | 2.3 | No | ||
9 | 61 | F | Breast staging | 2.6−3.8 | No | ||
10 | 80 | F | Lung staging | 5.8−8.1 | No | ||
11 | 65 | F | Lung staging | 3.2−5.1 | No | Pneumonectomy | No |
12 | 61 | M | Esophageal restaging | 2.9−4.8 | No | Fine-needle aspiration | No |
13 | 65 | M | Lung staging | 2.5−2.7 | No | ||
14 | 52 | F | Lymphoma staging | 2.0 | No | ||
15 | 65 | M | Colorectal staging | 1.8 | No | ||
16 | 51 | F | Colorectal staging | 3.3 | No | Mediastinoscopy | Yes |
17 | 72 | M | Lung staging | 4.4 | No | Pneumonectomy | No |
18 | 52 | F | Colorectal staging | 3.9 | No | ||
19 | 79 | M | Lung staging | 2.4−5.7 | No | Pneumonectomy | No |
20 | 40 | F | Pancreatic restaging | 2.8 | No | ||
21 | 47 | F | Cervical restaging | 3.3 | No | ||
22 | 37 | M | Colorectal restaging* | 5.6 | No | ||
23 | 67 | M | Colorectal staging* | 12.1 | No | ||
24 | 63 | F | Lymphoma restaging* | 4.5 | Yes | Incomplete colonoscopy | Not applicable |
↵* Patients 22−24 were prospectively recruited for virtual PET/CT colonoscopy after abnormal results on, or incomplete, conventional colonoscopy.
SUV = standardized uptake value.